2017 Harrington Scholar-Innovator

In NPC, misfolded proteins trigger a series of events at the molecular level that result in loss of nerve cells in the brain. The Ory lab aims to develop a small molecule that targets a protein-folding pathway, causing proteins to fold correctly and move to their correct location in the cell.

With support from Harrington Discovery Institute, Dr. Ory hopes to develop the next generation of drugs for NPC, potentially targeting the protein-folding pathway.